JNJ, GSK, LLY Announce M&A Deals at JP Morgan Conference
J&J announces a big deal to acquire neuroscience company ITCI for $14.6 billion, while Lilly and GSK announce smaller deals.
precisionmedicineonline18h
Eli Lilly to Acquire Scorpion Therapeutics' Mutant PI3Kα Inhibitor for $2.5B
NEW YORK – Eli Lilly on Monday said it will acquire Scorpion Therapeutics' mutant-PI3Kα inhibitor STX-478 for up to $2.5 billion while Scorpion spins out a new entity to develop its non-PI3Kα assets.
The Pharma Letter22h
Lilly takes a nibble at Scorpion program
US pharma major Eli Lilly is to buy the PI3Kα inhibitor program STX-478 from Scorpion Therapeutics, a private US biotech ...
Daily22h
Copycat weight-loss drugs: Eli Lilly sues two medical spas
Two medical spas have been sued by Eli Lilly for selling unapproved products that claim to contain tirzepatide. Tirzepatide ...
Daily23h
Eli Lilly to acquire Scorpion Therapeutics mutant-selective PI3Kα inhibitor program
Indianapolis: Eli Lilly and Company and Scorpion Therapeutics, Inc., a private biotechnology company developing small ...